{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:07:54Z","timestamp":1792454874238,"version":"4.5.0"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03112","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T04:32:07Z","timestamp":1547094727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":86,"title":["Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors"],"prefix":"10.3389","volume":"9","author":[{"given":"Alexandre Thibault Jacques","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Partouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radjiv","family":"Goulabchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Rozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bourgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"B3","unstructured":"Epid\u00e9miologie Nationale du Cancer: Incidence et Mortalit\u00e9 en 20172017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.14740\/jocmr2606w","article-title":"Systemic sclerosis and malignancy: a review of current data","volume":"8","author":"Zeineddine","year":"2016","journal-title":"J Clin Med Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/BOR.0000000000000222","article-title":"Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening","volume":"27","author":"Shah","year":"2015","journal-title":"Curr Opin Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with Anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/art.38928","article-title":"Review: cancer-induced autoimmunity in the rheumatic diseases","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5301\/jsrd.5000250","article-title":"Mechanistic and clinical insights at the scleroderma-cancer interface","volume":"2","author":"Shah","year":"2017","journal-title":"J Scleroderma Relat Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis","year":"1995","journal-title":"J Natl Cancer Inst."},{"key":"B11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med."},{"key":"B12","first-page":"651","article-title":"Bleomycin-induced scleroderma","volume":"7","author":"Finch","year":"1980","journal-title":"J Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1001\/jama.1991.03460240088033","article-title":"Exaggerated radiation-induced fibrosis in patients with systemic sclerosis","volume":"265","author":"Varga","year":"1991","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.jaad.2001.07.001","article-title":"Gemcitabine-associated scleroderma-like changes of the lower extremities","volume":"51","author":"Bessis","year":"2004","journal-title":"J Am Acad Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I\/III antibodies","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B17","doi-asserted-by":"publisher","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","article-title":"Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer","volume":"113","author":"Xu","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/SMJ.0b013e31815838ce","article-title":"Systemic sclerosis and malignancy: a review of the literature","volume":"101","author":"Wooten","year":"2008","journal-title":"South Med J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1365-2133.2010.09861.x","article-title":"Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study","volume":"163","author":"Olesen","year":"2010","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1136\/annrheumdis-2018-212999","article-title":"Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer","volume":"77","author":"Igusa","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T","article-title":"Incidence of cancer among patients with systemic sclerosis","volume":"76","author":"Rosenthal","year":"1995","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study","volume":"62","author":"Hill","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/03009742.2011.618145","article-title":"Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan","volume":"41","author":"Kuo","year":"2012","journal-title":"Scand J Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1002\/art.21225","article-title":"Risk of malignancy in scleroderma: a population-based cohort study","volume":"52","author":"Chatterjee","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B28","first-page":"1136","article-title":"Incidence of lung cancer in systemic sclerosis","volume":"12","author":"Peters-Golden","year":"1985","journal-title":"J Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/art.1780281204","article-title":"Cancer and systemic sclerosis. An epidemiologic study","volume":"28","author":"Roumm","year":"1985","journal-title":"Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.autrev.2013.09.006","article-title":"Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based cancer registry and review of the literature","volume":"13","author":"Colaci","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s10067-004-0940-5","article-title":"Association between systemic sclerosis and breast cancer: eight new cases and review of the literature","volume":"23","author":"Launay","year":"2004","journal-title":"Clin Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s10067-007-0546-9","article-title":"Associations of breast cancer development in patients with systemic sclerosis: an exploratory study","volume":"26","author":"Derk","year":"2007","journal-title":"Clin Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.autrev.2017.03.012","article-title":"Novel risk factors related to cancer in scleroderma","volume":"16","author":"Bernal-Bello","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/rheumatology\/36.4.426","article-title":"High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis","volume":"36","author":"Straub","year":"1997","journal-title":"Br J Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"25998","DOI":"10.1038\/srep25998","article-title":"Plasma prolactin and breast cancer risk: a meta- analysis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0159672","DOI":"10.1371\/journal.pone.0159672","article-title":"The use of antihypertensive medication and the risk of breast cancer in a case-control study in a Spanish population: the MCC-Spain study","volume":"11","author":"Gomez-Acebo","year":"2016","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.autrev.2014.03.003","article-title":"Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene?","volume":"13","author":"Bernal-Bello","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1158\/1055-9965.EPI-17-0096","article-title":"Use of calcium channel blockers and breast cancer risk in the Women's health initiative","volume":"26","author":"Brasky","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"B42","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/art.21261","article-title":"Prevalence of Barrett's esophagus in systemic sclerosis","volume":"52","author":"Wipff","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/rheumatology\/ker110","article-title":"Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR scleroderma trials and research prospective follow-up study","volume":"50","author":"Wipff","year":"2011","journal-title":"Rheumatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-009-1286-9","article-title":"Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review","volume":"29","author":"Vettori","year":"2010","journal-title":"Clin Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/art.23267","article-title":"Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma","volume":"58","author":"Mellemkjaer","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-016-3288-8","article-title":"Risk factors for malignancy in systemic sclerosis patients","volume":"35","author":"Kasifoglu","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/rheumatology\/ken442","article-title":"Reports of abnormal cervical cancer screening tests in systemic sclerosis","volume":"48","author":"Bernatsky","year":"2009","journal-title":"Rheumatology"},{"key":"B50","first-page":"S145","article-title":"Screening of human papillomavirus infection in women with systemic sclerosis","volume":"32","author":"Martin","year":"2014","journal-title":"Clin Exp Rheumatol."},{"key":"B51","first-page":"1763","article-title":"Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide","volume":"31","author":"Ognenovski","year":"2004","journal-title":"J Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-06-0591","article-title":"Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis","volume":"156","author":"Antonelli","year":"2007","journal-title":"Eur J Endocrinol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/rheumatology\/kev358","article-title":"Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis","volume":"55","author":"Antonelli","year":"2016","journal-title":"Rheumatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1136\/bcr-2014-205737","article-title":"Squamous cell carcinoma and eosinophilia in a long-term course of pansclerotic morphea","author":"Grewal","year":"2014","journal-title":"BMJ Case Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.mayocp.2017.03.016","article-title":"Scleroderma Induced by pembrolizumab: a case series","volume":"92","author":"Barbosa","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"B56","first-page":"263","article-title":"Systemic sclerosis induced by interferon-alfa treatment of melanoma","volume":"42","author":"Silva","year":"2017","journal-title":"Acta Reumatol Port"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1111\/1346-8138.14492","article-title":"Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma","volume":"46","author":"Cho","year":"2019","journal-title":"J Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0248-8663(97)82475-7","article-title":"[Systemic scleroderma and sarcoma of the mesentery]","volume":"18","author":"Cleenewerck","year":"1997","journal-title":"Rev Med Interne"},{"key":"B59","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00007611-200295030-00016","article-title":"Dermatofibrosarcoma protuberans with lung metastasis in a patient with progressive systemic sclerosis","volume":"95","author":"Westermann","year":"2002","journal-title":"South Med J."},{"key":"B60","first-page":"20","article-title":"Angiosarcoma arising in sclerodermatous skin","volume":"14","author":"Puizina-Ivic","year":"2005","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat."},{"key":"B61","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1468-3083.2006.01550.x","article-title":"Leiomyosarcoma of the chest wall with cutaneous metastases to the scalp in a patient with systemic sclerosis","volume":"20","author":"Banka","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B62","first-page":"468","article-title":"Angiosarcoma complicating systemic sclerosis: a case report","volume":"81","author":"Fonder","year":"2008","journal-title":"Cutis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/1346-8138.12705","article-title":"Angiosarcoma of the scalp in a patient with systemic sclerosis","volume":"42","author":"Kubota","year":"2015","journal-title":"J Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.arbres.2016.06.019","article-title":"Systemic sclerosis and Kaposi's sarcoma with pulmonary involvement: an unexpected association","volume":"53","author":"Aguiar","year":"2017","journal-title":"Arch Bronconeumol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","article-title":"Inflammation: gearing the journey to cancer","volume":"659","author":"Kundu","year":"2008","journal-title":"Mutat Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ceb.2016.07.010","article-title":"Inflammation and cancer: tissue regeneration gone awry","volume":"43","author":"Pesic","year":"2016","journal-title":"Curr Opin Cell Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"B70","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MCP.0000000000000217","article-title":"Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update","volume":"21","author":"Antoniou","year":"2015","journal-title":"Curr Opin Pulm Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3816\/CLC.2003.n.021","article-title":"The potential contributions of chronic inflammation to lung carcinogenesis","volume":"5","author":"Ballaz","year":"2003","journal-title":"Clin Lung Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2169\/internalmedicine.44.315","article-title":"Small cell lung cancer associated with systemic sclerosis","volume":"44","author":"Kanaji","year":"2005","journal-title":"Intern Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.rmed.2013.11.013","article-title":"Lung cancer risk among patients with combined pulmonary fibrosis and emphysema","volume":"108","author":"Kwak","year":"2014","journal-title":"Respir Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1002\/cam4.858","article-title":"The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema","volume":"5","author":"Zhang","year":"2016","journal-title":"Cancer Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e0134092","DOI":"10.1371\/journal.pone.0134092","article-title":"Partially Evoked Epithelial-Mesenchymal Transition (EMT) is associated with increased TGFbeta signaling within lesional scleroderma skin","volume":"10","author":"Nikitorowicz-Buniak","year":"2015","journal-title":"PLoS ONE"},{"key":"B77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fimmu.2018.00449","article-title":"Gene profiling in patients with systemic sclerosis reveals the presence of oncogenic gene signatures","volume":"9","author":"Dolcino","year":"2018","journal-title":"Front Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/ijms19020482","article-title":"Telomere length dynamics and the evolution of cancer genome architecture","volume":"19","author":"Cleal","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/rheumatology\/35.8.732","article-title":"Telomere reduction in scleroderma patients: a possible cause for chromosomal instability","volume":"35","author":"Artlett","year":"1996","journal-title":"Br J Rheumatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00296-007-0472-9","article-title":"Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, but markedly decreased in systemic sclerosis","volume":"28","author":"Tarhan","year":"2008","journal-title":"Rheumatol Int."},{"key":"B81","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand J Rheumatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/gene.2014.44","article-title":"Emerging role of epigenetics in systemic sclerosis pathogenesis","volume":"15","author":"Ciechomska","year":"2014","journal-title":"Genes Immun."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.34376","article-title":"DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility","volume":"64","author":"Lian","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jcmm.12105","article-title":"Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma","volume":"17","author":"Wang","year":"2013","journal-title":"J Cell Mol Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.clim.2012.01.005","article-title":"Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis","volume":"143","author":"Jiang","year":"2012","journal-title":"Clin Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2012.01.017","article-title":"Epigenetic patterns in systemic sclerosis and their contribution to attenuated CD70 signaling cascades","volume":"143","author":"Hedrich","year":"2012","journal-title":"Clin Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/onc.2014.162","article-title":"The ets transcription factor Fli-1 in development, cancer and disease","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ajpath.2011.01.002","article-title":"Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis","volume":"178","author":"Hu","year":"2011","journal-title":"Am J Pathol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1_1","article-title":"Cancer epigenetics: an introduction","volume":"1238","author":"Kanwal","year":"2015","journal-title":"Methods Mol Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2014.11.006","article-title":"Epigenetic targets for novel therapies of lung diseases","volume":"147","author":"Comer","year":"2015","journal-title":"Pharmacol Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/jid.2012.479","article-title":"p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta: epigenetic feed-forward amplification of fibrosis","volume":"133","author":"Ghosh","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11926-018-0724-6","article-title":"Sirtuins and accelerated aging in scleroderma","volume":"20","author":"Wyman","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MCO.0000000000000219","article-title":"Sirtuin-dependent clock control: new advances in metabolism, aging and cancer","volume":"18","author":"Masri","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s10875-013-9896-z","article-title":"MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression","volume":"33","author":"Zhu","year":"2013","journal-title":"J Clin Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/jcm5040042","article-title":"Considering exosomal miR-21 as a biomarker for cancer","volume":"5","author":"Shi","year":"2016","journal-title":"J Clin Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B100","doi-asserted-by":"publisher","first-page":"160125","DOI":"10.1183\/16000617.0125-2016","article-title":"A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis","volume":"26","author":"Bagnato","year":"2017","journal-title":"Eur Respir Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.3233\/thc-150943","article-title":"MiR-29 mediates TGFbeta 1-induced extracellular matrix synthesis through activation of Wnt\/beta -catenin pathway in human pulmonary fibroblasts","volume":"23","author":"Wang","year":"2015","journal-title":"Technol Health Care"},{"key":"B102","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.3892\/mmr.2018.8778","article-title":"miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns","volume":"17","author":"Bibaki","year":"2018","journal-title":"Mol Med Rep."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.200911-1698OC","article-title":"Inhibition and role of let-7d in idiopathic pulmonary fibrosis","volume":"182","author":"Pandit","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00403-012-1287-4","article-title":"microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma","volume":"305","author":"Etoh","year":"2013","journal-title":"Arch Dermatol Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2015.11.004","article-title":"Role of extracellular vesicles in autoimmune diseases","volume":"15","author":"Turpin","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B107","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2006.01.035","article-title":"Breast cancer markers","volume":"243","author":"Giancotti","year":"2006","journal-title":"Cancer Lett."},{"key":"B109","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.25056","article-title":"The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis","volume":"62","author":"Reich","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.autrev.2014.08.028","article-title":"Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis","volume":"13","author":"Yan","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/jid.2011.156","article-title":"Loss of PTEN expression by dermal fibroblasts causes skin fibrosis","volume":"131","author":"Parapuram","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1002\/art.38121","article-title":"Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64282-4","article-title":"Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis","volume":"162","author":"Chilosi","year":"2003","journal-title":"Am J Pathol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","article-title":"WNT signaling in cancer immunosurveillance","volume":"29","author":"Galluzzi","year":"2018","journal-title":"Trends Cell Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat Commun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/art.34424","article-title":"Wnt\/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells","volume":"64","author":"Wei","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B117","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.arcmed.2010.05.009","article-title":"Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies?","volume":"41","author":"Qian","year":"2010","journal-title":"Arch Med Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Del","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B119","doi-asserted-by":"publisher","first-page":"51630","DOI":"10.1074\/jbc.M409214200","article-title":"Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2\/9) secretion","volume":"279","author":"Williams","year":"2004","journal-title":"J Biol Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00420-016-1169-8","article-title":"Exposure to silicon carbide and cancer risk: a systematic review","volume":"90","author":"Boffetta","year":"2017","journal-title":"Int Arch Occup Environ Health"},{"key":"B121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","article-title":"Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature","volume":"13","author":"Marie","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie","year":"2015","journal-title":"Semin Immunopathol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaad.2014.11.027","article-title":"Association of occupational exposure with features of systemic sclerosis","volume":"72","author":"Marie","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.autrev.2017.01.004","article-title":"Systemic sclerosis and exposure to heavy metals: a case control study of 100 patients and 300 controls","volume":"16","author":"Marie","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/ard.42.4.368","article-title":"The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up","volume":"42","author":"Baltus","year":"1983","journal-title":"Ann Rheum Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.40114","article-title":"Mycophenolate Mofetil versus placebo for systemic sclerosis-related interstitial lung disease: an analysis of scleroderma lung studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3899\/jrheum.080611","article-title":"Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil","volume":"36","author":"Gulamhusein","year":"2009","journal-title":"J Rheumatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/bjd.13899","article-title":"Glycosaminoglycan and versican deposits in taxane-induced sclerosis","volume":"173","author":"Okada","year":"2015","journal-title":"Br J Dermatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"4249157","DOI":"10.1155\/2017\/4249157","article-title":"Docetaxel-induced systemic sclerosis with internal organ involvement masquerading as congestive heart failure","volume":"2017","author":"Park","year":"2017","journal-title":"Case Reports Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/toxsci\/kfv017","article-title":"Docetaxel facilitates endothelial dysfunction through oxidative stress via modulation of protein kinase C Beta: the protective effects of sotrastaurin","volume":"145","author":"Hung","year":"2015","journal-title":"Toxicol Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3315\/jdcr.2012.1106","article-title":"Post-irradiation morphea: case report and review of the literature","volume":"6","author":"Alhathlool","year":"2012","journal-title":"J Dermatol Case Rep."},{"key":"B134","first-page":"1601","article-title":"Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy","volume":"20","author":"Abu-Shakra","year":"1993","journal-title":"J Rheumatol."},{"key":"B135","first-page":"2265","article-title":"De novo systemic sclerosis after radiotherapy: a report of 3 cases","volume":"26","author":"Darras-Joly","year":"1999","journal-title":"J Rheumatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","article-title":"Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review","volume":"53","author":"Ferreli","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/2211-5463.12268","article-title":"A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice","volume":"7","author":"Yang","year":"2017","journal-title":"FEBS Open Bio"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3389\/fimmu.2018.01611","article-title":"IL-1-IL-17 signaling axis contributes to fibrosis and inflammation in two different murine models of systemic sclerosis","volume":"9","author":"Park","year":"2018","journal-title":"Front Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cup.13273","article-title":"Scleroderma-like skin changes induced by checkpoint inhibitor therapy","volume":"45","author":"Tjarks","year":"2018","journal-title":"J Cutan Pathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.40065","article-title":"Brief report: anti-RNPC-3 antibodies as a marker of cancer-associated scleroderma","volume":"69","author":"Shah","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2017.05.023","article-title":"Auto-antibodies and cancer in systemic sclerosis","volume":"16","author":"Boonstra","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B144","first-page":"1393","article-title":"Antinuclear antibodies as potential markers of lung cancer","volume":"5","author":"Fernandez-Madrid","year":"1999","journal-title":"Clin Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.05.002","article-title":"Antinuclear antibodies and cancer: a literature review","volume":"127","author":"Vlagea","year":"2018","journal-title":"Crit Rev Oncol Hematol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B147","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1084\/jem.173.6.1433","article-title":"Induction of autoreactive B cells allows priming of autoreactive T cells","volume":"173","author":"Lin","year":"1991","journal-title":"J Exp Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T04:32:18Z","timestamp":1547094738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":150,"alternative-id":["10.3389\/fimmu.2018.03112"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03112","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"article-number":"3112"}}